| Literature DB >> 34281061 |
Anna Książek1, Aleksandra Zagrodna1, Anna Bohdanowicz-Pawlak2, Felicja Lwow3, Małgorzata Słowińska-Lisowska1.
Abstract
Vitamin D affects both innate and adaptive immunity. Most of the effects of vitamin D on innate immunity are anti-inflammatory. In monocytes/macrophages, vitamin D suppresses the production of the inflammatory cytokines TNF-alpha, IL-1beta, IL-6, and IL-8. Therefore, the aim of our study was to investigate the relationship between 25(OH)D concentration and selected cytokines-IL-6, TNF-α, and IL-1β, which are hemogram parameters for professional football players. We enrolled 41 Polish premier league soccer players. The mean age, career duration, and VO2max were, respectively: 22.7 ± 5.3 years, 14.7 ± 4.5 years, and 55.8 ± 4.0 mL/kg/min. Serum levels of 25(OH)D were measured by electrochemiluminescence (ECLIA) using the Elecsys system (Roche, Switzerland). Serum levels of IL-6, IL-1β, and TNF-α were measured by ELISA (R&D Systems, Minneapolis). Blood count with smear was measured on a Sysmex XT-4000i analyzer (Sysmex Corporation, Japan). Our study showed decreased serum 25(OH)D levels in 78% of the professional players. We found a significant negative correlation between 25(OH)D levels and TNF-α and LYMPH (%). The results also demonstrated a statistically significant positive correlation between vitamin D levels and NEUTH (%), NEUTH (tys/µL), and EOS (tys/µL). Based on the results of our study, we concluded that football players from Poland are not protected against vitamin D insufficiency in winter months. Moreover, vitamin D deficiency may be associated with an increased pro-inflammatory risk in well-trained athletes.Entities:
Keywords: 25(OH)D; athletes; competitive period; pro-inflammatory cytokines
Mesh:
Substances:
Year: 2021 PMID: 34281061 PMCID: PMC8297090 DOI: 10.3390/ijerph18137124
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Participants’ characteristics.
| Characteristics | Mean ± SD ( |
|---|---|
| Age [years] | 22.7 ± 5.3 |
| Body weight [kg] | 76.3 ± 7.4 |
| Height [m] | 1.82 ± 6.7 |
| Body fat [%] | 19.1 ± 3.2 |
| VO2max [mL/kg/min] | 55.8 ± 4.0 |
| Career duration [years] | 14.7 ± 4.5 |
VO2max: maximal oxygen uptake.
Hemogram parameters of the study group.
| Mean ± SD ( | |
|---|---|
| WBC (tys/µL) [4.0–10.0] | 5.68 ± 1.62 |
| % NEUTH (%) [40–74] | 48.3 ± 9.78 |
| % LYMPH (%) [19–48] | 37.4 ± 8.44 |
| % EOS (%) [0.5–6.0] | 3.4 ± 2.49 |
| # NEUTH (tys/µL) [1.9–8.0] | 2.82 ± 1.39 |
| # LYMPH (tys/µL) [0.9–4.5] | 2.06 ± 0.58 |
| # EOS (tys/µL) [0.05–0.5] | 0.19 ± 0.14 |
| PLT (tys/µL) [130–440] | 219.49 ± 46.29 |
| MPV (fL) [7.2–12] | 8.03 ± 0.84 |
| PLR | 34.1 ± 5.2 |
| NLR | 1.53 ± 1.23 |
Cytokine levels and hemogram parameters (mean ± SD) relative to 25(OH)D levels.
| Serum 25(OH)D Concentration (ng/mL) | |||
|---|---|---|---|
| <20 | ≥20 |
| |
| IL-1β (pg/mL) | 2.4 ± 2.2 | 1.7 ± 1.5 | 0.572 |
| IL-6 (pg/mL) | 0.86 ± 0.78 | 0.73 ± 0.37 | 0.613 |
| TNF-α (pg/mL) | 1.46 ± 0.26 | 1.46 ± 0.29 | 0.971 |
| WBC (tys/µL) | 5.64 ± 1.73 | 5.81 ± 1.29 | 0.601 |
| % NEUTH (%) | 47.5 ± 10.6 | 51.4 ± 6.2 | 0.124 |
| % LYMPH (%) | 38.4 ± 9.1 * | 33.5 ± 4.4 * | 0.02 |
| % EOS (%) | 3.02 ± 2.07 | 4.83 ± 3.55 | 0.060 |
| # NEUTH (tys/µL) | 2.77 ± 1.52 | 3.00 ± 0.83 | 0.215 |
| # LYMPH (tys/µL) | 2.09 ± 0.61 | 1.94 ± 0.50 | 0.516 |
| # EOS (tys/µL) | 0.168 ± 0.116 * | 0.288 ± 0.184 * | 0.028 |
| PLT (tys/µL) | 219 ± 47 | 221 ± 51 | 0.902 |
| MPV (fL) | 8.03 ± 0.83 | 8.00 ± 0.97 | 0.914 |
| PLR | 112.5 ± 35.4 | 118.2 ± 30.4 | 0.521 |
| NLR | 1.51 ± 0.37 * | 1.59 ± 0.40 * | 0.035 |
* p < 0.05.
Correlation between 25(OH)D levels and IL-6, IL-1β, and TNF-α in athletes.
| 25(OH)D (ng/mL) | ||
|---|---|---|
| Rho |
| |
| IL-1β (pg/mL) | −0.16 | 0.34 |
| IL-6 (pg/mL) | −0.14 | 0.41 |
| TNF0α (pg/mL) | −0.47 * | 0.004 |
* p < 0.01.
Correlations between 25(OH)D concentration and hemogram parameters.
| 25(OH)D (ng/mL) | ||
|---|---|---|
| Rho |
| |
| WBC (tys/µL) | 0.08 | 0.62 |
| % NEUTH (%) | 0.49 * | 0.02 |
| % LYMPH (%) | −0.50 * | 0.02 |
| % EOS (%) | 0.26 | 0.09 |
| # NEUTH (tys/µL) | 0.49 * | 0.02 |
| # LYMPH (tys/µL) | −0.06 | 0.71 |
| # EOS (tys/µL) | 0.31 * | 0.049 |
| PLT (tys/µL) | 0.14 | 0.37 |
| MPV (fL) | 0.08 | 0.63 |
| PLR | 0.079 | 0.612 |
| NLR | 0.197 | 0.204 |
* p < 0.01.